<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>ARKG filings -- what changed, from SEC Form N-PORT | Mulden</title><description>Each N-PORT filing of ARKG compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.</description><link>https://themulden.com/</link><language>en</language><item><title>ARKG: filing for 2026-04-30 -- 5 added, 7 dropped, turnover 14.8%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>35 positions became 33: 5 added (3.88% of the fund), 7 dropped (5.2%). Turnover proxy 14.8%. Largest increases: ABSCI CORP 2.83% to 4.79%; TWIST BIOSCIENCE CORP 7.21% to 9.02%; COMPASS PATHWAYS PLC 1.13% to 2.44%; TEMPUS AI INC 8.27% to 9.45%; CRISPR THERAPEUTICS AG 8.01% to 8.94%; INTELLIA THERAPEUTICS INC 3.1% to 3.83%. Largest decreases: PERSONALIS INC 6.15% to 3.59%; GUARDANT HEALTH INC 6% to 3.51%; IONIS PHARMACEUTICALS INC 2.62% to 1.75%; ADAPTIVE BIOTECHNOLOGIES CORP 3.13% to 2.43%; VERACYTE INC 3.29% to 2.67%; PACIFIC BIOSCIENCES OF CALIFORNIA INC 1.98% to 1.41%. New: ALAMAR BIOSCIENCES INC (1.21%), BIONTECH SE (1.07%), ELI LILLY &amp;amp; COMPANY (0.95%), GENERATE BIOMEDICINES INC (0.52%), Goldman Sachs Financial Square Treasury Obligations Fund (0.13%). Gone: Amgen Inc (1.21%), Incyte Corp (1.07%), Vertex Pharmaceuticals Inc (0.96%), Caris Life Sciences Inc (0.74%), Veeva Systems Inc (0.66%), Standard BioTools Inc (0.34%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 23 Jun 2026 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2026-01-30 -- 1 added, 3 dropped, turnover 12.1%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>37 positions became 35: 1 added (0.98% of the fund), 3 dropped (3.65%). Turnover proxy 12.1%. Largest increases: Twist Bioscience Corp 5.3% to 7.21%; 10X Genomics Inc 3.41% to 5.23%; Guardant Health Inc 4.93% to 6%; Beam Therapeutics Inc 3.78% to 4.81%; CareDx Inc 2.45% to 3.44%; Illumina Inc 3.72% to 4.53%. Largest decreases: Tempus AI Inc 10.2% to 8.27%; Absci Corp 3.81% to 2.83%; Ionis Pharmaceuticals Inc 3.49% to 2.62%; Recursion Pharmaceuticals Inc 4.83% to 4.01%; CRISPR Therapeutics AG 8.77% to 8.01%; Schrodinger Inc/United States 3.08% to 2.33%. New: AtaiBeckley Inc (0.98%). Gone: Exact Sciences Corp (1.68%), ATAI Life Sciences NV (1.36%), Regeneron Pharmaceuticals Inc (0.61%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2025-10-31 -- 2 added, 0 dropped, turnover 10%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>35 positions became 37: 2 added (2.78% of the fund), 0 dropped (0%). Turnover proxy 10%. Largest increases: Personalis Inc 3.8% to 5.85%; Tempus AI Inc 8.82% to 10.2%; ATAI Life Sciences NV 0.64% to 1.36%; Illumina Inc 3.05% to 3.72%; Absci Corp 3.29% to 3.81%; Pacific Biosciences of Califor 1.51% to 1.95%. Largest decreases: Recursion Pharmaceuticals Inc 6.79% to 4.83%; CRISPR Therapeutics AG 10.55% to 8.77%; Twist Bioscience Corp 7% to 5.3%; 10X Genomics Inc 4.35% to 3.41%; Schrodinger Inc/United States 3.89% to 3.08%; Amgen Inc 1.66% to 1.1%. New: Exact Sciences Corp (1.68%), GeneDx Holdings Corp (1.09%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 29 Dec 2025 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2025-07-31 -- 2 added, 0 dropped, turnover 12.2%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>33 positions became 35: 2 added (1.17% of the fund), 0 dropped (0%). Turnover proxy 12.2%. Largest increases: CRISPR Therapeutics AG 7.95% to 10.55%; Illumina Inc 1.15% to 3.05%; 10X Genomics Inc 2.82% to 4.35%; Prime Medicine Inc 0.42% to 1.72%; Personalis Inc 2.69% to 3.8%; Intellia Therapeutics Inc 2.68% to 3.34%. Largest decreases: Guardant Health Inc 6.45% to 4.65%; Natera Inc 5.95% to 4.39%; Twist Bioscience Corp 8.5% to 7%; Schrodinger Inc/United States 5.32% to 3.89%; CareDx Inc 3.83% to 2.51%; Adaptive Biotechnologies Corp 4.61% to 3.52%. New: ATAI Life Sciences NV (0.64%), Caris Life Sciences Inc (0.53%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 23 Sep 2025 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2025-04-30 -- 1 added, 4 dropped, turnover 9.4%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>36 positions became 33: 1 added (0.45% of the fund), 4 dropped (2.25%). Turnover proxy 9.4%. Largest increases: Tempus AI Inc 6.47% to 8.32%; CRISPR Therapeutics AG 6.51% to 7.95%; Natera Inc 4.85% to 5.95%; 908 Devices Inc 0.57% to 1.52%; Guardant Health Inc 5.56% to 6.45%; Schrodinger Inc/United States 4.55% to 5.32%. Largest decreases: Veracyte Inc 4.65% to 3.69%; Twist Bioscience Corp 9.42% to 8.5%; 10X Genomics Inc 3.52% to 2.82%; CareDx Inc 4.49% to 3.83%; Adaptive Biotechnologies Corp 5.25% to 4.61%; Butterfly Network Inc 2.22% to 1.59%. New: Goldman Sachs Financial Square Treasury Obligations Fund (0.45%). Gone: Accolade Inc (1.62%), Exact Sciences Corp (0.36%), Repare Therapeutics Inc (0.2%), Goldman Sachs Financial Square Treasury Obligations Fund (0.07%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 25 Jun 2025 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2025-01-31 -- 0 added, 2 dropped, turnover 13.9%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>38 positions became 36: 0 added (0% of the fund), 2 dropped (1.13%). Turnover proxy 13.9%. Largest increases: Tempus AI Inc 3% to 6.47%; Guardant Health Inc 2.73% to 5.56%; Illumina Inc 0.51% to 1.72%; Schrodinger Inc/United States 3.39% to 4.55%; Natera Inc 3.75% to 4.85%; Twist Bioscience Corp 8.37% to 9.42%. Largest decreases: Nurix Therapeutics Inc 4.22% to 2.48%; Ionis Pharmaceuticals Inc 4.39% to 2.69%; Intellia Therapeutics Inc 3.73% to 2.54%; Exact Sciences Corp 1.29% to 0.36%; Veeva Systems Inc 2.14% to 1.26%; Standard BioTools Inc 1.16% to 0.42%. Gone: Moderna Inc (1.1%), Senti Biosciences Inc (0.03%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 28 Mar 2025 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2024-10-31 -- 1 added, 4 dropped, turnover 13.5%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>41 positions became 38: 1 added (0.51% of the fund), 4 dropped (2.55%). Turnover proxy 13.5%. Largest increases: Natera Inc 1.15% to 3.75%; Recursion Pharmaceuticals Inc 5.44% to 6.89%; Personalis Inc 1.51% to 2.95%; Veracyte Inc 3.24% to 4.61%; Tempus AI Inc 1.92% to 3%; Adaptive Biotechnologies Corp 3.75% to 4.63%. Largest decreases: Moderna Inc 2.85% to 1.1%; CareDx Inc 6.68% to 5.08%; Twist Bioscience Corp 9.8% to 8.37%; Intellia Therapeutics Inc 4.78% to 3.73%; Beam Therapeutics Inc 4.46% to 3.53%; Vertex Pharmaceuticals Inc 2.54% to 1.62%. New: Illumina Inc (0.51%). Gone: Verve Therapeutics Inc (1.16%), Teladoc Health Inc (0.85%), Ginkgo Bioworks Holdings Inc (0.54%), UiPath Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 26 Dec 2024 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2024-07-31 -- 2 added, 2 dropped, turnover 18%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>41 positions became 41: 2 added (1.95% of the fund), 2 dropped (0.05%). Turnover proxy 18%. Largest increases: CareDx Inc 3.47% to 6.68%; Twist Bioscience Corp 6.78% to 9.8%; Adaptive Biotechnologies Corp 2.11% to 3.75%; Guardant Health Inc 0.5% to 2.01%; Nurix Therapeutics Inc 2.42% to 3.45%; Beam Therapeutics Inc 3.48% to 4.46%. Largest decreases: Exact Sciences Corp 5.27% to 1.06%; Ginkgo Bioworks Holdings Inc 3.6% to 0.54%; Teladoc Health Inc 3.31% to 0.85%; Accolade Inc 3.27% to 1.57%; UiPath Inc 1.12% to 0%; Schrodinger Inc/United States 4.69% to 3.7%. New: Tempus AI Inc (1.92%), Senti Biosciences Inc (0.03%). Gone: Senti Biosciences Inc (0.04%), Senti Biosciences Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 26 Sep 2024 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2024-04-30 -- 1 added, 3 dropped, turnover 12.1%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>43 positions became 41: 1 added (0.59% of the fund), 3 dropped (1.63%). Turnover proxy 12.1%. Largest increases: Twist Bioscience Corp 5.22% to 6.78%; Moderna Inc 2.13% to 3.29%; Nurix Therapeutics Inc 1.3% to 2.42%; Absci Corp 0.1% to 1.19%; Intellia Therapeutics Inc 2.99% to 3.93%; Standard BioTools Inc 1.84% to 2.47%. Largest decreases: Exact Sciences Corp 8.2% to 5.27%; Pacific Biosciences of Califor 4.42% to 1.53%; Teladoc Health Inc 4.44% to 3.31%; UiPath Inc 2.23% to 1.12%; Accolade Inc 3.96% to 3.27%; Verve Therapeutics Inc 1.91% to 1.39%. New: Natera Inc (0.59%). Gone: NVIDIA Corp (1.24%), Invitae Corp (0.2%), Pfizer Inc (0.19%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 26 Jun 2024 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2024-01-31 -- 3 added, 1 dropped, turnover 15.2%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>41 positions became 43: 3 added (2.49% of the fund), 1 dropped (2.02%). Turnover proxy 15.2%. Largest increases: CRISPR Therapeutics AG 4.39% to 6.62%; Recursion Pharmaceuticals Inc 2.76% to 4.91%; Twist Bioscience Corp 3.15% to 5.22%; 10X Genomics Inc 2% to 3.27%; Accolade Inc 2.69% to 3.96%; Arcturus Therapeutics Holdings 2.49% to 3.47%. Largest decreases: Exact Sciences Corp 10.77% to 8.2%; Ionis Pharmaceuticals Inc 6.35% to 4.58%; Ginkgo Bioworks Holdings Inc 4.98% to 3.68%; Adaptive Biotechnologies Corp 3.5% to 2.42%; UiPath Inc 3.11% to 2.23%; Intellia Therapeutics Inc 3.84% to 2.99%. New: Standard BioTools Inc (1.84%), Amgen Inc (0.54%), Absci Corp (0.1%). Gone: SomaLogic Inc (2.02%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 21 Mar 2024 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2023-10-31 -- 1 added, 5 dropped, turnover 11.7%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>45 positions became 41: 1 added (0.3% of the fund), 5 dropped (0.77%). Turnover proxy 11.7%. Largest increases: Ionis Pharmaceuticals Inc 4.16% to 6.35%; Vertex Pharmaceuticals Inc 1.69% to 2.86%; Veeva Systems Inc 1.7% to 2.64%; CRISPR Therapeutics AG 3.54% to 4.39%; Beam Therapeutics Inc 2.69% to 3.48%; SomaLogic Inc 1.29% to 2.02%. Largest decreases: Schrodinger Inc/United States 7.37% to 4.22%; NVIDIA Corp 2.68% to 1.09%; Quantum-Si Inc 2.31% to 1.18%; Pacific Biosciences of Califor 6% to 5.04%; Accolade Inc 3.58% to 2.69%; Butterfly Network Inc 1.36% to 0.74%. New: Goldman Sachs Financial Square Treasury Obligations Fund (0.3%). Gone: Codexis Inc (0.5%), GOLDMAN FS TRSY OBLIG INS (0.2%), PhenomeX Inc (0.05%), Iovance Biotherapeutics Inc (0.01%), Surface Oncology Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 27 Dec 2023 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2023-07-31 -- 0 added, 0 dropped, turnover 10%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>45 positions became 45: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 10%. Largest increases: Recursion Pharmaceuticals Inc 0.89% to 2.86%; Ginkgo Bioworks Holdings Inc 3.14% to 5.11%; Quantum-Si Inc 0.9% to 2.31%; Schrodinger Inc/United States 6.02% to 7.37%; Twist Bioscience Corp 1.94% to 2.9%; Exact Sciences Corp 9.89% to 10.43%. Largest decreases: Incyte Corp 2.72% to 1.31%; Beam Therapeutics Inc 3.5% to 2.69%; Ionis Pharmaceuticals Inc 4.87% to 4.16%; SomaLogic Inc 1.93% to 1.29%; Teladoc Health Inc 5.48% to 4.84%; Accolade Inc 4.18% to 3.58%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 27 Sep 2023 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2023-04-28 -- 1 added, 3 dropped, turnover 10%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>47 positions became 45: 1 added (0.09% of the fund), 3 dropped (0.68%). Turnover proxy 10%. Largest increases: Schrodinger Inc/United States 4.22% to 6.02%; Accolade Inc 2.81% to 4.18%; NVIDIA Corp 1.5% to 2.49%; Arcturus Therapeutics Holdings 1.87% to 2.76%; Pacific Biosciences of Califor 5.56% to 6.21%; CRISPR Therapeutics AG 3.56% to 4.06%. Largest decreases: Twist Bioscience Corp 3.7% to 1.94%; Exact Sciences Corp 11.39% to 9.89%; CareDx Inc 4.25% to 2.87%; Incyte Corp 3.57% to 2.72%; Ginkgo Bioworks Holdings Inc 3.83% to 3.14%; Beam Therapeutics Inc 4.1% to 3.5%. New: GOLDMAN FS TRSY OBLIG INS (0.09%). Gone: Dreyfus Government Cash Management (0.47%), ATAI Life Sciences NV (0.2%), Organovo Holdings Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 23 Jun 2023 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2023-01-31 -- 0 added, 2 dropped, turnover 13.3%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>49 positions became 47: 0 added (0% of the fund), 2 dropped (4.15%). Turnover proxy 13.3%. Largest increases: Exact Sciences Corp 6.93% to 11.39%; Pacific Biosciences of Califor 4.2% to 5.56%; Adaptive Biotechnologies Corp 3.01% to 3.81%; 10X Genomics Inc 1.02% to 1.76%; Compass Pathways Plc 0.47% to 0.99%; Veracyte Inc 2% to 2.49%. Largest decreases: Ionis Pharmaceuticals Inc 6.03% to 4.7%; Butterfly Network Inc 2.16% to 1.16%; Verve Therapeutics Inc 3.79% to 2.81%; CareDx Inc 5.2% to 4.25%; 908 Devices Inc 2.46% to 1.52%; Ginkgo Bioworks Holdings Inc 4.51% to 3.83%. Gone: Fate Therapeutics Inc (3.59%), Signify Health Inc (0.56%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 24 Mar 2023 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2022-10-31 -- 3 added, 3 dropped, turnover 14.7%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>49 positions became 49: 3 added (2.51% of the fund), 3 dropped (1.96%). Turnover proxy 14.7%. Largest increases: Pacific Biosciences of Califor 1.89% to 4.2%; Ginkgo Bioworks Holdings Inc 2.45% to 4.51%; Verve Therapeutics Inc 1.97% to 3.79%; CareDx Inc 3.75% to 5.2%; Butterfly Network Inc 1.33% to 2.16%; Ionis Pharmaceuticals Inc 5.21% to 6.03%. Largest decreases: Signify Health Inc 4.9% to 0.56%; CRISPR Therapeutics AG 4.69% to 3.57%; Fate Therapeutics Inc 4.64% to 3.59%; Beam Therapeutics Inc 4.59% to 3.69%; Twist Bioscience Corp 4.09% to 3.29%; Exact Sciences Corp 7.55% to 6.93%. New: NVIDIA Corp (1.04%), Prime Medicine Inc (1.01%), Compass Pathways Plc (0.47%). Gone: 1Life Healthcare Inc (1.11%), Zymergen Inc (0.69%), Compugen Ltd (0.15%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 27 Dec 2022 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2022-07-29 -- 4 added, 4 dropped, turnover 14.9%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>49 positions became 49: 4 added (2.29% of the fund), 4 dropped (1.81%). Turnover proxy 14.9%. Largest increases: Twist Bioscience Corp 2.44% to 4.09%; Beam Therapeutics Inc 2.95% to 4.59%; Schrodinger Inc/United States 2.58% to 3.86%; CRISPR Therapeutics AG 3.6% to 4.69%; Verve Therapeutics Inc 0.93% to 1.97%; Intellia Therapeutics Inc 3.35% to 4.1%. Largest decreases: Ionis Pharmaceuticals Inc 8.36% to 5.21%; Exact Sciences Corp 9.16% to 7.55%; Vertex Pharmaceuticals Inc 3.86% to 2.35%; Pacific Biosciences of Califor 2.96% to 1.89%; Invitae Corp 1.13% to 0.37%; Codexis Inc 1.75% to 1.09%. New: Guardant Health Inc (1.02%), Moderna Inc (1%), Senti Biosciences Inc (0.24%), Senti Biosciences Inc (0.02%). Gone: Dynamics Special Purpose Corp (0.83%), Burning Rock Biotech Ltd (0.72%), Editas Medicine Inc (0.26%), Castle Biosciences Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 28 Sep 2022 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2022-04-29 -- 1 added, 5 dropped, turnover 12.5%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>53 positions became 49: 1 added (0.26% of the fund), 5 dropped (0.73%). Turnover proxy 12.5%. Largest increases: Ionis Pharmaceuticals Inc 5.47% to 8.36%; Signify Health Inc 2.83% to 4.27%; 908 Devices Inc 1.2% to 2.46%; Quantum-Si Inc 1.38% to 1.98%; SomaLogic Inc 1.56% to 2.13%; Schrodinger Inc/United States 2.03% to 2.58%. Largest decreases: Teladoc Health Inc 7.83% to 5.08%; Castle Biosciences Inc 1.28% to 0%; Accolade Inc 2.35% to 1.33%; Intellia Therapeutics Inc 4.34% to 3.35%; Beam Therapeutics Inc 3.83% to 2.95%; Pacific Biosciences of Califor 3.57% to 2.96%. New: ATAI Life Sciences NV (0.26%). Gone: Cellectis SA (0.44%), AquaBounty Technologies Inc (0.15%), Evogene Ltd (0.08%), Palantir Technologies Inc (0.06%), Takeda Pharmaceutical Co Ltd (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 24 Jun 2022 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2022-01-31 -- 2 added, 1 dropped, turnover 14.4%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>52 positions became 53: 2 added (0.51% of the fund), 1 dropped (0.23%). Turnover proxy 14.4%. Largest increases: Exact Sciences Corp 5.43% to 8.72%; Ionis Pharmaceuticals Inc 3.76% to 5.47%; Intellia Therapeutics Inc 3.15% to 4.34%; Beam Therapeutics Inc 2.8% to 3.83%; CareDx Inc 2.72% to 3.71%; Fate Therapeutics Inc 3.57% to 4.44%. Largest decreases: Takeda Pharmaceutical Co Ltd 2.45% to 0%; Pacific Biosciences of Califor 5.3% to 3.57%; Regeneron Pharmaceuticals Inc 2.62% to 1.03%; Teladoc Health Inc 8.93% to 7.83%; Twist Bioscience Corp 3.63% to 2.84%; Accolade Inc 3.08% to 2.35%. New: Burning Rock Biotech Ltd (0.32%), Nurix Therapeutics Inc (0.18%). Gone: NanoString Technologies Inc (0.23%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 23 Mar 2022 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2021-10-29 -- 4 added, 12 dropped, turnover 17%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>60 positions became 52: 4 added (6.27% of the fund), 12 dropped (9.02%). Turnover proxy 17%. Largest increases: Teladoc Health Inc 6.91% to 8.93%; Beam Therapeutics Inc 1.83% to 2.8%; Arcturus Therapeutics Holdings 0.99% to 1.76%; Codexis Inc 1.58% to 2.35%; Invitae Corp 1.5% to 2.21%; Intellia Therapeutics Inc 2.48% to 3.15%. Largest decreases: Regeneron Pharmaceuticals Inc 4.58% to 2.62%; Veeva Systems Inc 3.16% to 1.78%; CareDx Inc 3.61% to 2.72%; Fate Therapeutics Inc 4.16% to 3.57%; Vertex Pharmaceuticals Inc 4.25% to 3.74%; Berkeley Lights Inc 1.69% to 1.25%. New: Ginkgo Bioworks Holdings Inc (3.02%), Pfizer Inc (1.34%), SomaLogic Inc (1.32%), Palantir Technologies Inc (0.58%). Gone: Novartis AG (2.72%), Roche Holding AG (2.48%), Bristol-Myers Squibb Co (1.03%), Sema4 Holdings Corp (0.59%), Seer Inc (0.47%), Sarepta Therapeutics Inc (0.38%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 23 Dec 2021 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2021-07-30 -- 6 added, 6 dropped, turnover 13.9%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>60 positions became 60: 6 added (2.94% of the fund), 6 dropped (3.74%). Turnover proxy 13.9%. Largest increases: UiPath Inc 0.45% to 1.73%; Ionis Pharmaceuticals Inc 2.65% to 3.9%; Pacific Biosciences of Califor 4.29% to 5.36%; Intellia Therapeutics Inc 1.42% to 2.48%; Signify Health Inc 0.61% to 1.62%; Fate Therapeutics Inc 3.45% to 4.16%. Largest decreases: Pure Storage Inc 1.41% to 0.34%; 10X Genomics Inc 2.73% to 1.69%; Sarepta Therapeutics Inc 1.38% to 0.38%; Novartis AG 3.71% to 2.72%; Iovance Biotherapeutics Inc 2.47% to 1.63%; Roche Holding AG 3.3% to 2.48%. New: Verve Therapeutics Inc (0.86%), Quantum-Si Inc (0.83%), Sema4 Holdings Corp (0.59%), Caribou Biosciences Inc (0.28%), Dynamics Special Purpose Corp (0.23%), Dicerna Pharmaceuticals Inc (0.14%). Gone: Guardant Health Inc (1.17%), Thermo Fisher Scientific Inc (0.92%), AbbVie Inc (0.65%), CM Life Sciences Inc (0.61%), Phreesia Inc (0.3%), Syros Pharmaceuticals Inc (0.09%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 24 Sep 2021 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2021-04-30 -- 10 added, 4 dropped, turnover 15.2%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>54 positions became 60: 10 added (4.6% of the fund), 4 dropped (1.95%). Turnover proxy 15.2%. Largest increases: 10X Genomics Inc 1.59% to 2.73%; Exact Sciences Corp 3.98% to 5.08%; Veeva Systems Inc 1.53% to 2.48%; Accolade Inc 1.94% to 2.81%; Regeneron Pharmaceuticals Inc 3.82% to 4.54%; Novartis AG 3.05% to 3.71%. Largest decreases: Twist Bioscience Corp 5.61% to 4.09%; Arcturus Therapeutics Holdings 2.63% to 1.23%; Pacific Biosciences of Califor 5.4% to 4.29%; Invitae Corp 2.82% to 1.83%; Personalis Inc 2.39% to 1.41%; CRISPR Therapeutics AG 3.53% to 2.58%. New: Butterfly Network Inc (0.99%), AbbVie Inc (0.65%), Signify Health Inc (0.61%), CM Life Sciences Inc (0.61%), Seer Inc (0.45%), UiPath Inc (0.45%). Gone: Alphabet Inc (1.37%), Longview Acquisition Corp (0.33%), MS USD LIQ (0.17%), Hims &amp;amp; Hers Health Inc (0.08%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 24 Jun 2021 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2021-01-29 -- 9 added, 2 dropped, turnover 32.8%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>47 positions became 54: 9 added (10.28% of the fund), 2 dropped (2.47%). Turnover proxy 32.8%. Largest increases: Teladoc Health Inc 3.35% to 7.97%; Regeneron Pharmaceuticals Inc 0.52% to 3.82%; Takeda Pharmaceutical Co Ltd 1.09% to 3.14%; Novartis AG 1.01% to 3.05%; Vertex Pharmaceuticals Inc 1.57% to 3.44%; Berkeley Lights Inc 0.27% to 1.55%. Largest decreases: Invitae Corp 8.84% to 2.82%; CRISPR Therapeutics AG 8.44% to 3.53%; Arcturus Therapeutics Holdings 5.75% to 2.63%; Seres Therapeutics Inc 3.38% to 0.78%; Compugen Ltd 2.82% to 0.64%; Pacific Biosciences of Califor 7.19% to 5.4%. New: Roche Holding AG (3.67%), Bristol-Myers Squibb Co (1.53%), Veeva Systems Inc (1.53%), Alphabet Inc (1.37%), Sarepta Therapeutics Inc (1.35%), Longview Acquisition Corp (0.33%). Gone: Illumina Inc (2.47%), Apple Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 19 Mar 2021 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2020-10-30 -- 10 added, 4 dropped, turnover 22.7%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>41 positions became 47: 10 added (7.76% of the fund), 4 dropped (2%). Turnover proxy 22.7%. Largest increases: Pacific Biosciences of Califor 2.26% to 7.19%; Seres Therapeutics Inc 0.89% to 3.38%; Teladoc Health Inc 0.99% to 3.35%; Accolade Inc 0.52% to 1.44%; Personalis Inc 2.65% to 3.5%; Twist Bioscience Corp 4.09% to 4.61%. Largest decreases: Illumina Inc 5.73% to 2.47%; CRISPR Therapeutics AG 11.02% to 8.44%; Compugen Ltd 5.14% to 2.82%; Invitae Corp 10.71% to 8.84%; Guardant Health Inc 2.55% to 1.06%; Cerus Corp 2.93% to 1.54%. New: Exact Sciences Corp (3.41%), Takeda Pharmaceutical Co Ltd (1.09%), Novartis AG (1.01%), Beam Therapeutics Inc (0.63%), Thermo Fisher Scientific Inc (0.57%), Regeneron Pharmaceuticals Inc (0.52%). Gone: Inovio Pharmaceuticals Inc (1.1%), Cellular Biomedicine Group Inc (0.58%), Organovo Holdings Inc (0.32%), Precigen Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 28 Dec 2020 12:00:00 GMT</pubDate></item><item><title>ARKG: filing for 2020-07-31 -- 5 added, 1 dropped, turnover 15.8%</title><link>https://themulden.com/funds/arkg/</link><guid isPermaLink="true">https://themulden.com/funds/arkg/</guid><description>37 positions became 41: 5 added (3.85% of the fund), 1 dropped (0%). Turnover proxy 15.8%. Largest increases: CRISPR Therapeutics AG 7.93% to 11.02%; Invitae Corp 8.92% to 10.71%; 10X Genomics Inc 0.77% to 2.43%; Twist Bioscience Corp 3.15% to 4.09%; Personalis Inc 1.71% to 2.65%; Pure Storage Inc 1.64% to 2.54%. Largest decreases: Illumina Inc 8.95% to 5.73%; Compugen Ltd 7.85% to 5.14%; Arcturus Therapeutics Holdings 8.94% to 6.45%; Intellia Therapeutics Inc 4.42% to 2.78%; NanoString Technologies Inc 2.43% to 1.41%; Codexis Inc 1.72% to 0.87%. New: Vertex Pharmaceuticals Inc (1.86%), Schrodinger Inc/United States (0.83%), Accolade Inc (0.52%), Phreesia Inc (0.51%), Berkeley Lights Inc (0.12%). Gone: Bellicum Pharmaceuticals Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 25 Sep 2020 12:00:00 GMT</pubDate></item></channel></rss>